Cancer Communications

Papers
(The TQCC of Cancer Communications is 14. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-08-01 to 2025-08-01.)
ArticleCitations
Issue Information750
Issue Information450
403
263
Single‐cell transcriptomics and epigenomics point to CD58‐CD2 interaction in controlling primary melanoma growth and immunity248
Issue Information237
Nine‐fold variation of risk of advanced colorectal neoplasms according to smoking and polygenic risk score: Results from a cross‐sectional study in a large screening colonoscopy cohort214
189
Loss of CDKN1B induces an age‐related clonal hematopoietic disorder via Notch2 activity dysregulation173
Fascin lysine 471 acetylation cooperates with serine 39 phosphorylation to inhibit actin‐bundling activity and tumor metastasis in esophageal squamous cell carcinoma171
Defining and tracing subtypes of patient‐derived xenograft models in pancreatic ductal adenocarcinoma155
Age‐specific effectiveness of primary human papillomavirus screening versus cytology in a cervical cancer screening program: a nationwide cross‐sectional study153
Long‐term survival outcomes and immune checkpoint inhibitor retreatment in patients with advanced cervical cancer treated with camrelizumab plus apatinib in the phase II CLAP study144
Kindlin‐1 drives early steps of breast cancer metastasis135
Current status and perspectives of esophageal cancer: a comprehensive review135
The Chinese Society of Clinical Oncology (CSCO): Clinical guidelines for the diagnosis and treatment of colorectal cancer, 2024 update134
Combined local therapy and CAR‐GPC3 T‐cell therapy in advanced hepatocellular carcinoma: a proof‐of‐concept treatment strategy134
Signaling pathways in cancer‐associated fibroblasts: recent advances and future perspectives130
Issue Information108
Validation of different personalized risk models of chemotherapy‐induced nausea and vomiting: results of a randomized, double‐blind, phase III trial of fosaprepitant for cancer patients treated with h106
P300/CBP‐associated factor (PCAF)‐mediated acetylation of Fascin at lysine 471 inhibits its actin‐bundling activity and tumor metastasis in esophageal cancer103
Partial hepatectomy versus interventional treatment in patients with hepatitis B virus‐related hepatocellular carcinoma and clinically significant portal hypertension: a randomized comparative clinica103
Predictive power of tertiary lymphoid structure signature for neoadjuvant chemotherapy response and immunotherapy benefit in HER2‐negative breast cancer99
p38γ and p38δ as biomarkers in the interplay of colon cancer and inflammatory bowel diseases98
Impact of pre‐existing cardiometabolic diseases on metastatic cancer stage at diagnosis: a prospective multinational cohort study97
Nasopharyngeal carcinoma treatment paradigm after HK0501 – a potential way forward96
Research trends of cancer metabolism: analysis from a Chinese perspective92
A nanotherapeutic strategy to target drug‐tolerant cells and overcome EGFR tyrosine kinase inhibitor resistance in lung cancer91
Single‐cell transcriptomics provides insights into the origin and immune microenvironment of cervical precancerous lesions89
Efficacy and safety of first‐line sintilimab plus anlotinib versus chemotherapy for metastatic non‐small cell lung cancer: a phase II, open‐label, randomized controlled trial87
85
HSF1 facilitates the multistep process of lymphatic metastasis in bladder cancer via a novel PRMT5‐WDR5‐dependent transcriptional program76
Oral transforming growth factor‐beta receptor 1 inhibitor vactosertib promotes osteosarcoma regression by targeting tumor proliferation and enhancing anti‐tumor immunity74
Residual circulating tumor DNA after adjuvant chemotherapy effectively predicts recurrence of stage II‐III gastric cancer74
Combined treatment of non‐small cell lung cancer using radiotherapy and immunotherapy: challenges and updates74
N6‐methyladenosine‐regulated exosome biogenesis orchestrates an immunosuppressive pre‐metastatic niche in gastric cancer peritoneal metastasis70
Comparative single‐cell analysis of esophageal cancer subtypes reveals tumor microenvironment distinctions explaining varied immunotherapy responses67
Development and validation of an artificial intelligence model for predicting post‐transplant hepatocellular cancer recurrence61
Multifunctional inorganic nanomaterials for cancer photoimmunotherapy59
Issue Information58
57
Acquired RD3 loss regulates immune surveillance in high‐risk and therapy defying progressive neuroblastoma56
Association between antipsychotic agents and risk of lung cancer: a nested case‐control study50
47
A multimodal integrative approach to model transcriptional addiction of thyroid cancer on RUNX247
Cover Image, Volume 42, Issue 147
Targeting IL‐17A to manage immunotherapy‐induced toxicity in melanoma44
FOXO1 or not FOXO1: that is the question44
Impact of small molecule‐mediated inhibition of ammonia detoxification on lung malignancies and liver metabolism43
Incidence of and survival with bone and soft tissue sarcoma: A nation‐wide study over four decades42
Comprehensive DSRCT multi‐omics analyses unveil CACNA2D2 as a diagnostic hallmark and super‐enhancer‐driven EWSR1::WT1 signature gene42
Antitumoral effects of cannabis in Notch1‐mutated T‐cell acute lymphoblastic leukemia41
Intercellular communications and metabolic reprogramming as new predictive markers for immunotherapy responses in gastric cancer41
A strong internal promoter drives massive expression of YEATS‐domain devoid MLLT3 transcripts in HSC and most lethal AML41
Ubiquitination in cancer: mechanisms and therapeutic opportunities40
Cover Image, Volume 45, Issue 640
Novel molecular mechanisms of immune evasion in hepatocellular carcinoma: NSUN2‐mediated increase of SOAT2 RNA methylation38
Association of previously irradiated stable brain metastases with outcomes of atezolizumab‐treated non‐small cell lung cancer: A pooled analysis of individual patient data from three randomized trials38
First‐line serplulimab plus chemotherapy in extensive‐stage small‐cell lung cancer: Updated results and biomarker analysis from the ASTRUM‐005 randomized clinical trial38
Functions and clinical significance of mechanical tumor microenvironment: cancer cell sensing, mechanobiology and metastasis37
Correction to: ZNF582 hypermethylation promotes metastasis of nasopharyngeal carcinoma by regulating the transcription of adhesion molecules Nectin‐3 and NRXN337
Transcriptomic analyses of localized prostate cancers of East Asian and North American men reveal race‐specific luminal‐basal and microenvironmental differences35
Issue Information35
Low household income and income volatility increase risk of lung cancer: A nationwide retrospective cohort study34
Transcriptional suppression of CD8+ T cell exhaustion for improving T cell immunotherapy33
Novel strategy for disease risk prediction incorporating predicted gene expression and DNA methylation data: a multi‐phased study of prostate cancer33
An HGF‐dependent positive feedback loop between bladder cancer cells and fibroblasts mediates lymphangiogenesis and lymphatic metastasis32
m6A‐modified EHD1 controls PD‐L1 endosomal trafficking to modulate immune evasion and immunotherapy responses in lung adenocarcinoma30
Enhanced selection of people for lung cancer screening using AHRR (cg05575921) or F2RL3 (cg03636183) methylation as biological markers of smoking exposure29
Development of antibody‐drug conjugates in cancer: Overview and prospects28
Breast cancer: an up‐to‐date review and future perspectives28
Long‐term outcomes of intraoperative radiotherapy for early‐stage breast cancer in China: a multicenter real‐world study28
circCAPRIN1 interacts with STAT2 to promote tumor progression and lipid synthesis via upregulating ACC1 expression in colorectal cancer27
Genomic characterization reveals distinct mutation landscapes and therapeutic implications in neuroendocrine carcinomas of the gastrointestinal tract27
Spatial metabolomics for evaluating response to neoadjuvant therapy in non‐small cell lung cancer patients26
Genomic information of children with malignant brain tumors for the prediction of length of hospitalization26
JUPITER‐02 trial: advancing survival for recurrent metastatic nasopharyngeal carcinoma and next steps26
Inhibition of mTOR attenuates the initiation and progression of BRCA1‐associated mammary tumors26
Long‐term antibiotic use and risk of hepatocellular carcinoma later in life: a nationwide cohort study of 9.8 million participants26
4‐1BB transcriptomic expression patterns across malignancies: Implications for clinical trials of 4‐1BB agonists26
N‐acetyltransferase 10 promotes colon cancer progression by inhibiting ferroptosis through N4‐acetylation and stabilization of ferroptosis suppressor protein 1 (FSP1) mRNA25
Gene expression profiling improves prognostication by nomogram in patients with soft‐tissue sarcomas25
DNA methylation signature predicts cancer response to demethylation agents from profiling diverse cancer cell lines25
Artificial intelligence for assisting cancer diagnosis and treatment in the era of precision medicine25
24
Sunitinib in metastatic renal cell carcinoma: clinical outcomes across risk groups in a Turkish Oncology Group Kidney Cancer Consortium23
Issue Information23
Single‐cell and bulk transcriptomics identifies a tumor‐specific CD36+ cancer‐associated fibroblast subpopulation in colorectal cancer23
Knowing nodal Rouviére: the power of human intelligence in toxicity reduction23
Issue Information23
Galectin 3‐binding protein (LGALS3BP) depletion attenuates hepatic fibrosis by reducing transforming growth factor‐β1 (TGF‐β1) availability and inhibits hepatocarcinogenesis22
The E3 ubiquitin ligase HUWE1 acts through the N‐Myc‐DLL1‐NOTCH1 signaling axis to suppress glioblastoma progression22
Pancreatic cancer survival trends in the US from 2001 to 2014: a CONCORD‐3 study22
Effect of neutrophils on tumor immunity and immunotherapy resistance with underlying mechanisms21
Combination of photodynamic therapy and stimulator of interferon genes (STING) agonist inhibits colorectal tumor growth and recurrence21
A moonlighting function of choline kinase alpha 2 in the initiation of lipid droplet lipolysis in cancer cells20
Enhancement of CAR‐T cell activity against cholangiocarcinoma by simultaneous knockdown of six inhibitory membrane proteins20
Issue Information20
Cover Image, Volume 44, Issue 420
Breaking barriers: Smart vaccine platforms for cancer immunomodulation20
Cover Image, Volume 43, Issue 620
Lipid metabolism reprograming by SREBP1‐PCSK9 targeting sensitizes pancreatic cancer to immunochemotherapy20
Ex vivo STAT3 phosphorylation in circulating immune cells: a novel biomarker for early cancer diagnosis and response to anti‐PD‐1 therapy20
Tumor microenvironment signaling and therapeutics in cancer progression20
A single measurement of fecal hemoglobin concentration outperforms polygenic risk score in colorectal cancer risk assessment19
Advanced precision modeling reveals divergent responses of hepatocellular carcinoma to combinatorial immunotherapy19
Leptin‐mediated suppression of lipoprotein lipase cleavage enhances lipid uptake and facilitates lymph node metastasis in gastric cancer19
Targeting ferroptosis resistance resensitizes metastatic HR+HER2− breast cancer cells to palbociclib‐hormone therapy19
18
The efficacy and possible mechanisms of immune checkpoint inhibitors in treating non‐small cell lung cancer patients with epidermal growth factor receptor mutation18
Enhancing sensitivity of triple‐negative breast cancer to DNA‐damaging therapy through chemical inhibition of the m6A methyltransferase METTL318
Beyond success: unveiling the hidden potential of radiotherapy and immunotherapy in solid tumors17
17
Single‐cell‐eQTL mapping in circulating immune cells reveals genetic regulation of response‐associated networks in lung cancer immunotherapy17
The regulatory roles and clinical significance of glycolysis in tumor17
Real‐world outcomes of niraparib treatment in patients with ovarian cancer: a multicenter non‐interventional study in China16
Concurrent chemoradiotherapyof different radiation doses and different irradiation fields for locally advanced thoracic esophageal squamous cell carcinoma: A randomized, multicenter, phase III clinica16
Proteomic identification of new diagnostic biomarkers of early‐stage cutaneous mycosis fungoides16
Lysosomal TMEM9‐LAMTOR4‐controlled mTOR signaling integrity is required for mammary tumorigenesis16
The SARS‐CoV‐2 spike protein induces lung cancer migration and invasion in a TLR2‐dependent manner16
RGS12 inhibits the progression and metastasis of multiple myeloma by driving M1 macrophage polarization and activation in the bone marrow microenvironment16
Safety and immunogenicity of a third dose of mRNA‐1273 vaccine among cancer patients16
Targeting N4‐acetylcytidine suppresses hepatocellular carcinoma progression by repressing eEF2‐mediated HMGB2 mRNA translation16
Issue Information16
Single‐cell atlas reveals a distinct immune profile fostered by T cell‐B cell crosstalk in triple negative breast cancer16
Evolution of tumor microenvironment in colorectal liver metastases under treatment stress16
Perivascular localized cells commit erythropoiesis in PDGF‐B‐expressing solid tumors16
Ferroptosis in cancer and cancer immunotherapy16
Infection complications in febrile chimeric antigen receptor (CAR)‐T recipients during the peri‐CAR‐T cell treatment period examined using metagenomic next‐generation sequencing (mNGS)16
Issue Information15
Tumor‐derived insulin‐like growth factor‐binding protein‐1 contributes to resistance of hepatocellular carcinoma to tyrosine kinase inhibitors15
Cancer diagnosis is one quarter lower than the expected cancer incidence in the first year of COVID‐19 pandemic in Germany: A retrospective register‐based cohort study15
Issue Information15
Dlk1 is a novel adrenocortical stem/progenitor cell marker that predicts malignancy in adrenocortical carcinoma14
Unraveling the routes to distant metastases in colorectal cancer: Tumor deposits and lymph node metastases as the gateway14
Diagnostic value of genetic mutation analysis and mutation profiling of cell‐free DNA in intraocular fluid for vitreoretinal lymphoma14
Discovery of a novel viroid‐like circular RNA in colorectal cancer14
Targeted STAT1 therapy for LZTR1‐driven peripheral nerve sheath tumor14
14
Efficacy, safety and biomarkers of SG001 for patients with previously treated recurrent or metastatic cervical cancer: an open‐label, multicenter, phase Ib trial14
ABTL0812 enhances antitumor effect of paclitaxel and reverts chemoresistance in triple‐negative breast cancer models14
0.046591997146606